Immunization, Vaccines and Biologicals, World Health Organization, CH-1211 Geneva 27, Switzerland.
PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.
Vaccine. 2017 Dec 14;35(49 Pt A):6793-6797. doi: 10.1016/j.vaccine.2017.04.063. Epub 2017 May 29.
Immunization program delivery strategies that enable high vaccine coverage, particularly in inaccessible and remote areas, are critical to achieving optimal vaccine impact. In addition to demonstration of safety and efficacy, there are many factors that influence whether a newly licensed vaccine will be introduced into a country's national immunization program, particularly in resource-constrained environments. This paper describes three case studies of novel approaches that represent the potential for improved programmatic impact by increasing vaccine accessibility in different ways. However, the pathway to regulatory approval, policy recommendation, and program introduction in low- and middle-income countries is complex, requiring engagement with multiple, diverse stakeholders. Consideration of aspects that affect uptake in low- and middle-income countries, during the product development stage, will help better position new or second-generation vaccine products for successful implementation to achieve public health impact.
免疫规划实施策略对于实现疫苗的最佳效果至关重要,这些策略能提高疫苗接种覆盖率,尤其是在难以到达和偏远地区。除了安全性和有效性的证明外,还有许多因素会影响新获得许可的疫苗是否会被引入到一个国家的国家免疫规划中,特别是在资源有限的环境中。本文描述了三种新方法的案例研究,这些方法代表了通过以不同方式提高疫苗可及性来提高规划影响的潜力。然而,在低收入和中等收入国家,获得监管批准、政策建议和方案实施的途径是复杂的,需要与多个不同的利益攸关方进行接触。在产品开发阶段考虑影响低收入和中等收入国家疫苗接种的因素,将有助于更好地为新的或第二代疫苗产品的成功实施定位,以实现公共卫生的影响。